AA
DVAX

Addison Advisors’s Dynavax Technologies DVAX Stock Holding History

Addison Advisors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300
Closed -$3K – 792
2022
Q3 		$3K Buy
+300
New +$3.91K ﹤0.01% 531

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Addison Advisors's DVAX Position: Q4 2022 in Review

Addison Advisors sold out of Dynavax Technologies (DVAX) in Q4 2022, closing a stake of 300 shares — an estimated $3K sold.

Addison Advisors first reported a position in DVAX in Q3 2022 and held it in 1 quarter. The position peaked at $3K in Q3 2022. 230 funds tracked by Wall St. Rank hold DVAX as of Q4 2022.

  • Addison Advisors reported no remaining Dynavax Technologies position as of Q4 2022 after selling out during the quarter.
  • Addison Advisors sold 300 Dynavax Technologies shares in Q4 2022, an estimated $3K.
  • Addison Advisors first reported a position in Dynavax Technologies in Q3 2022 and held it in 1 quarter.
  • Addison Advisors's Dynavax Technologies position peaked at $3K in Q3 2022.
  • 230 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2022.

Based on Addison Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.